Direct asymmetric Michael reactions of cyclic 1,3-dicarbonyl compounds and enamines catalyzed by chiral bisoxazoline-copper(II) complexes

Journal of Organic Chemistry

Volumn 68, Issue 13, 2003, Pages 5067-5074

  Halland, Nis ^a   Velgaard, Thomas ^a   Jørgensen, Karl Anker ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MICHAEL REACTIONS;

ADDITION REACTIONS; CATALYST ACTIVITY; COMPLEXATION; COPPER; ESTERS; UNSATURATED COMPOUNDS;

AMINES;

3 HYDROXY 1H PHENALEN 1 ONE; 4 HYDROXY 6 METHYL 2 PYRONE; 4 HYDROXYCOUMARIN DERIVATIVE; 5,5 DIMETHYL 1,3 CYCLOHEXANEDIONE; BISOXAZOLINE; CARBONYL DERIVATIVE; COPPER COMPLEX; ENAMINE; LAWSONE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CATALYST; CHIRALITY; COMPLEX FORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; MICHAEL ADDITION; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 0037534368     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0343026     Document Type: Article

References (41)

1. For reviews of enantioselective conjugate addition reactions, see: (a) Yamaguchi, M. Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999; Chapter 31.2. (b) Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56, 8033. (c) Krause, N.; Hoffmann-Röder, A. Synthesis 2001, 171.
2. For reviews of enantioselective conjugate addition reactions, see: (a) Yamaguchi, M. Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999; Chapter 31.2. (b) Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56, 8033. (c) Krause, N.; Hoffmann-Röder, A. Synthesis 2001, 171.
3. For reviews of enantioselective conjugate addition reactions, see: (a) Yamaguchi, M. Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999; Chapter 31.2. (b) Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56, 8033. (c) Krause, N.; Hoffmann-Röder, A. Synthesis 2001, 171.
4. For biological and pharmaceutical activities see, e.g.: (a) Murray, R. D. H.; Medez, J.; Brown, S. A. The Natural Coumarins: Occurrence, Chemistry and Biochemistry; Wiley: New York, 1982. (b) The Handbook of Natural Flavonoids; Harborne, J. B., Baxter, H., Eds.; Wiley: Chichester, UK, 1999. (c) Manolov, I.; Danchev, N. D. Eur. J. Med. Chem. 1995, 30, 531. (d) Mouli, C.; Giridhar, T.; Rao. D. M.; Reddy, R. B. J. Heterocycl. Chem. 1996, 33, 5. (e) Rehse, K.; Schinkel, W. Arch. Pharm. 1983, 988.
5. For biological and pharmaceutical activities see, e.g.: (a) Murray, R. D. H.; Medez, J.; Brown, S. A. The Natural Coumarins: Occurrence, Chemistry and Biochemistry; Wiley: New York, 1982. (b) The Handbook of Natural Flavonoids; Harborne, J. B., Baxter, H., Eds.; Wiley: Chichester, UK, 1999. (c) Manolov, I.; Danchev, N. D. Eur. J. Med. Chem. 1995, 30, 531. (d) Mouli, C.; Giridhar, T.; Rao. D. M.; Reddy, R. B. J. Heterocycl. Chem. 1996, 33, 5. (e) Rehse, K.; Schinkel, W. Arch. Pharm. 1983, 988.
6. For biological and pharmaceutical activities see, e.g.: (a) Murray, R. D. H.; Medez, J.; Brown, S. A. The Natural Coumarins: Occurrence, Chemistry and Biochemistry; Wiley: New York, 1982. (b) The Handbook of Natural Flavonoids; Harborne, J. B., Baxter, H., Eds.; Wiley: Chichester, UK, 1999. (c) Manolov, I.; Danchev, N. D. Eur. J. Med. Chem. 1995, 30, 531. (d) Mouli, C.; Giridhar, T.; Rao. D. M.; Reddy, R. B. J. Heterocycl. Chem. 1996, 33, 5. (e) Rehse, K.; Schinkel, W. Arch. Pharm. 1983, 988.
7. For biological and pharmaceutical activities see, e.g.: (a) Murray, R. D. H.; Medez, J.; Brown, S. A. The Natural Coumarins: Occurrence, Chemistry and Biochemistry; Wiley: New York, 1982. (b) The Handbook of Natural Flavonoids; Harborne, J. B., Baxter, H., Eds.; Wiley: Chichester, UK, 1999. (c) Manolov, I.; Danchev, N. D. Eur. J. Med. Chem. 1995, 30, 531. (d) Mouli, C.; Giridhar, T.; Rao. D. M.; Reddy, R. B. J. Heterocycl. Chem. 1996, 33, 5. (e) Rehse, K.; Schinkel, W. Arch. Pharm. 1983, 988.
8. For biological and pharmaceutical activities see, e.g.: (a) Murray, R. D. H.; Medez, J.; Brown, S. A. The Natural Coumarins: Occurrence, Chemistry and Biochemistry; Wiley: New York, 1982. (b) The Handbook of Natural Flavonoids; Harborne, J. B., Baxter, H., Eds.; Wiley: Chichester, UK, 1999. (c) Manolov, I.; Danchev, N. D. Eur. J. Med. Chem. 1995, 30, 531. (d) Mouli, C.; Giridhar, T.; Rao. D. M.; Reddy, R. B. J. Heterocycl. Chem. 1996, 33, 5. (e) Rehse, K.; Schinkel, W. Arch. Pharm. 1983, 988.
9. (a) Ikawa, M.; Stahmann, M. A.; Link, K. P. J. Am. Chem. Soc. 1944, 66, 902.
10. (b) Ivanov, I. C.; Manolov, I.; Alexandrova, L. A. Arch. Pharm. 1990, 521.
11. (c) Talapatra, S. K.; Chakrabarti, R.; Mukhopadhyay, P. K.; Das, P. K.; Talapatra, B. Heterocycles 1984, 22, 519.
12. Itoh, K.; Kanemasa, S. Tetrahedron Lett. 2003, 44, 1799.
13. For examples of Lewis-acid-catalyzed enantioselective Michael additions of 1,3-dicarbonyls to acyclic substrates, see: (a) Hamashima, Y.; Hotta, D.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 11240. (b) End, N.; Macko, L.; Zehnder, M.; Pfaltz, A. Chem. Eur. J. 1998, 4, 818. (c) Ji, J.; Barnes, D. M.; Zhang, J.; King, S. A.; Wittenberger, S. J.; Morton, H. E. J. Am. Chem. Soc. 1999, 121, 10215. (d) Barnes, D. M.; Ji, J.; Fickles, M. G.; Fitzgerald, M. A.; King, S. A.; Morton, H. E.; Plagge, F. A.; Preskill, M.; Wagaw, S. H.; Wittenberger, S. J.; Zhang, J. J. Am. Chem. Soc. 2002, 124, 13097. (e) Christoffers, J.; Rößler, U.; Werner, T. Eur.
14. For examples of Lewis-acid-catalyzed enantioselective Michael additions of 1,3-dicarbonyls to acyclic substrates, see: (a) Hamashima, Y.; Hotta, D.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 11240. (b) End, N.; Macko, L.; Zehnder, M.; Pfaltz, A. Chem. Eur. J. 1998, 4, 818. (c) Ji, J.; Barnes, D. M.; Zhang, J.; King, S. A.; Wittenberger, S. J.; Morton, H. E. J. Am. Chem. Soc. 1999, 121, 10215. (d) Barnes, D. M.; Ji, J.; Fickles, M. G.; Fitzgerald, M. A.; King, S. A.; Morton, H. E.; Plagge, F. A.; Preskill, M.; Wagaw, S. H.; Wittenberger, S. J.; Zhang, J. J. Am. Chem. Soc. 2002, 124, 13097. (e) Christoffers, J.; Rößler, U.; Werner, T. Eur.
15. For examples of Lewis-acid-catalyzed enantioselective Michael additions of 1,3-dicarbonyls to acyclic substrates, see: (a) Hamashima, Y.; Hotta, D.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 11240. (b) End, N.; Macko, L.; Zehnder, M.; Pfaltz, A. Chem. Eur. J. 1998, 4, 818. (c) Ji, J.; Barnes, D. M.; Zhang, J.; King, S. A.; Wittenberger, S. J.; Morton, H. E. J. Am. Chem. Soc. 1999, 121, 10215. (d) Barnes, D. M.; Ji, J.; Fickles, M. G.; Fitzgerald, M. A.; King, S. A.; Morton, H. E.; Plagge, F. A.; Preskill, M.; Wagaw, S. H.; Wittenberger, S. J.; Zhang, J. J. Am. Chem. Soc. 2002, 124, 13097. (e) Christoffers, J.; Rößler, U.; Werner, T. Eur.
16. For examples of Lewis-acid-catalyzed enantioselective Michael additions of 1,3-dicarbonyls to acyclic substrates, see: (a) Hamashima, Y.; Hotta, D.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 11240. (b) End, N.; Macko, L.; Zehnder, M.; Pfaltz, A. Chem. Eur. J. 1998, 4, 818. (c) Ji, J.; Barnes, D. M.; Zhang, J.; King, S. A.; Wittenberger, S. J.; Morton, H. E. J. Am. Chem. Soc. 1999, 121, 10215. (d) Barnes, D. M.; Ji, J.; Fickles, M. G.; Fitzgerald, M. A.; King, S. A.; Morton, H. E.; Plagge, F. A.; Preskill, M.; Wagaw, S. H.; Wittenberger, S. J.; Zhang, J. J. Am. Chem. Soc. 2002, 124, 13097. (e) Christoffers, J.; Rößler, U.; Werner, T. Eur.
17. For examples of Lewis-acid-catalyzed enantioselective Michael additions of 1,3-dicarbonyls to acyclic substrates, see: (a) Hamashima, Y.; Hotta, D.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 11240. (b) End, N.; Macko, L.; Zehnder, M.; Pfaltz, A. Chem. Eur. J. 1998, 4, 818. (c) Ji, J.; Barnes, D. M.; Zhang, J.; King, S. A.; Wittenberger, S. J.; Morton, H. E. J. Am. Chem. Soc. 1999, 121, 10215. (d) Barnes, D. M.; Ji, J.; Fickles, M. G.; Fitzgerald, M. A.; King, S. A.; Morton, H. E.; Plagge, F. A.; Preskill, M.; Wagaw, S. H.; Wittenberger, S. J.; Zhang, J. J. Am. Chem. Soc. 2002, 124, 13097. (e) Christoffers, J.; Rößler, U.; Werner, T. Eur.
18. (a) O'Reilly, R. A. N. Engl. J. Med. 1976, 295, 354.
19. (b) Wingard, L. B.; O'Reilly, R. A.; Levy, G. Clin. Pharmacol. Ther. 1978, 23, 212.
20. (c) Bardsley, H. J.; Daly, A. K. PCT Patent WO 00/43003.
21. (d) Li, H.-Y.; Robinson, A. J. U.S. Patent 5,856,525, January 5, 1999.
22. (e) Li, H.-Y.; Robinson, A. J.; Feaster, J. Tetrahedron Lett. 1996, 37, 8321.
23. (f) Cravotto, G.; Nano, G. M.; Palmisano, G.; Tagliapietra, S. Tetrahedron: Asymmetry 2001,12,707.
24. (g) Demir, A. S.; Tanyeli, C.; Gulbeyaz, V.; Akgun, H. Turk. J. Chem. 1996, 20, 139.
25. Druzgala, P.; Zhang, X.; Pfister, J. R. PCT Pat. Appl. WO 02/085882.
26. 2-bisoxazoline - Lewis acid complexes as catalysts, see e.g.: (a) Ghosh, A. K.; Mathivanen, P.; Cappiello, J. Tetrahedron: Asymmetry 1998, 9, 1. (b) Jørgensen, K. A.; Johannsen, M.; Yao, S.; Audrain, H.; Thorhauge, J. Acc. Chem. Res. 1999, 32, 605. (c) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.
27. 2-bisoxazoline - Lewis acid complexes as catalysts, see e.g.: (a) Ghosh, A. K.; Mathivanen, P.; Cappiello, J. Tetrahedron: Asymmetry 1998, 9, 1. (b) Jørgensen, K. A.; Johannsen, M.; Yao, S.; Audrain, H.; Thorhauge, J. Acc. Chem. Res. 1999, 32, 605. (c) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.
28. 2-bisoxazoline - Lewis acid complexes as catalysts, see e.g.: (a) Ghosh, A. K.; Mathivanen, P.; Cappiello, J. Tetrahedron: Asymmetry 1998, 9, 1. (b) Jørgensen, K. A.; Johannsen, M.; Yao, S.; Audrain, H.; Thorhauge, J. Acc. Chem. Res. 1999, 32, 605. (c) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.
29. (a) Jensen, K. B.; Thorhauge, J.; Hazell, R. G.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2001, 40, 160.
30. (b) Zhuang, W.; Hansen, T.; Jørgensen, K. A. Chem. Commun. 2001, 347.
31. Use of chiral bisoxazoline-Lewis acid complexes for enantioselective Michael additions, see e.g.: (a) Kitajima, H.; Katsuki, T. Synlett 1997, 568. (b) Evans, D. A.; Scheidt, K. A.; Johnston, J. N. J. Am. Chem. Soc. 2001, 123, 4480. (c) Evans, D. A.; Rovis, T.; Kozlowski, M. C.; Tedrow, J. S. J. Am. Chem. Soc. 2000, 122, 9134. (d) Sibi. M. P.; Chen, J. Org. Lett. 2002, 4, 2933 and refs 5c and 5d.
32. Use of chiral bisoxazoline-Lewis acid complexes for enantioselective Michael additions, see e.g.: (a) Kitajima, H.; Katsuki, T. Synlett 1997, 568. (b) Evans, D. A.; Scheidt, K. A.; Johnston, J. N. J. Am. Chem. Soc. 2001, 123, 4480. (c) Evans, D. A.; Rovis, T.; Kozlowski, M. C.; Tedrow, J. S. J. Am. Chem. Soc. 2000, 122, 9134. (d) Sibi. M. P.; Chen, J. Org. Lett. 2002, 4, 2933 and refs 5c and 5d.
33. Use of chiral bisoxazoline-Lewis acid complexes for enantioselective Michael additions, see e.g.: (a) Kitajima, H.; Katsuki, T. Synlett 1997, 568. (b) Evans, D. A.; Scheidt, K. A.; Johnston, J. N. J. Am. Chem. Soc. 2001, 123, 4480. (c) Evans, D. A.; Rovis, T.; Kozlowski, M. C.; Tedrow, J. S. J. Am. Chem. Soc. 2000, 122, 9134. (d) Sibi. M. P.; Chen, J. Org. Lett. 2002, 4, 2933 and refs 5c and 5d.
34. Use of chiral bisoxazoline-Lewis acid complexes for enantioselective Michael additions, see e.g.: (a) Kitajima, H.; Katsuki, T. Synlett 1997, 568. (b) Evans, D. A.; Scheidt, K. A.; Johnston, J. N. J. Am. Chem. Soc. 2001, 123, 4480. (c) Evans, D. A.; Rovis, T.; Kozlowski, M. C.; Tedrow, J. S. J. Am. Chem. Soc. 2000, 122, 9134. (d) Sibi. M. P.; Chen, J. Org. Lett. 2002, 4, 2933 and refs 5c and 5d.
35. Equilibrium is sufficiently rapid so that only enantiomers are detected upon CSP-HPLC, and no diastereomers are observed. For equilibrium studies on related compounds, see: (a) Heimark, L. D.; Trager, W. F. J. Med. Chem. 1984, 27, 1092. (b) Porter, W. R.; Trager, W. F. J. Heterocycl. Chem. 1982, 19, 475.
36. Equilibrium is sufficiently rapid so that only enantiomers are detected upon CSP-HPLC, and no diastereomers are observed. For equilibrium studies on related compounds, see: (a) Heimark, L. D.; Trager, W. F. J. Med. Chem. 1984, 27, 1092. (b) Porter, W. R.; Trager, W. F. J. Heterocycl. Chem. 1982, 19, 475.
37. (a) Itoh, K.; Kanemasa, S. J. Am. Chem. Soc. 2002, 124, 13394.
38. (b) Nakama, K.; Seki, S.; Kanemasa, S. Tetrahedron Lett. 2002, 43, 829.
39. Li, H.-Y.; Boswell, G. A. Tetrahedron Lett. 1996, 37, 1551.
40. Audrain, H.; Thorhauge, J.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2000, 65, 4487.
41. Thorhauge, J.; Roberson, M.; Hazell, R. G.; Jørgensen, K. A. Chem. Eur. J. 2002, 8, 1888.